VistaGen Therapeutics VTGN
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.66 | 103.45 | -0.44 | -19,551 | -19 | |
| 2025Q3 | 3.55 | 103.28 | -0.55 | -20,054 | -19 | |
| 2025Q2 | 2.00 | 104.70 | -0.47 | -15,804 | -15 | |
| 2025Q1 | 2.50 | -0.44 | -14,495 | -14 | ||
| 2024Q4 | 2.95 | 107.32 | -0.46 | -15,120 | -14 | |
| 2024Q3 | 3.01 | 109.83 | -0.42 | -14,227 | -13 | |
| 2024Q2 | 3.48 | 113.03 | -0.35 | -12,131 | -11 | |
| 2024Q1 | 5.28 | 119.32 | -0.25 | -11,359 | -10 | |
| 2023Q4 | 5.14 | 124.16 | 0.28 | -7,884 | -6 | |
| 2023Q3 | 5.24 | 102.91 | -0.61 | -6,780 | -7 | |
| 2023Q2 | 1.87 | 101.41 | -0.94 | -6,998 | -7 | |
| 2023Q1 | 3.74 | 100.11 | -1.69 | -12,239 | -12 | |
| 2022Q4 | 3.09 | 100.05 | -1.41 | -9,767 | -10 | |
| 2022Q3 | 4.56 | -2.54 | -17,489 | -17 | ||
| 2022Q2 | 26.40 | 100.01 | -2.87 | -19,773 | -20 | |
| 2022Q1 | 37.20 | 100.03 | -2.58 | -16,693 | -17 | |
| 2021Q4 | 58.50 | 100.05 | -1.50 | -10,540 | -11 | |
| 2021Q3 | 82.20 | 100.04 | -2.10 | -12,800 | -13 | |
| 2021Q2 | 94.50 | -1.20 | -7,746 | -8 | ||
| 2021Q1 | 63.90 | 100.03 | -9.00 | -6,219 | -6 |